Published • loading... • Updated
Changes in Mifepristone Use at Pharmacies After Removal of the FDA In-Person Dispensing Requirement
Summary by JAMA Network
1 Articles
1 Articles
Changes in Mifepristone Use at Pharmacies After Removal of the FDA In-Person Dispensing Requirement
This cross-sectional study examines access to mifepristone through retail and mail-order pharmacies following the US Food and Drug Administration’s (FDA) removal of its in-person dispensing requirement.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
